Neurological disorders such as Alzheimer's disease and Parkinson's disease are pressing global health issues, contributing substantially to the worldwide disease burden. However, the availability of more effective and accurate research tools remains limited, partly due to incomplete understanding of the underlying mechanisms, including disease models, markers, and appropriate analysis platforms.
To address these challenges, ACROBiosystems launched Aneuro, a pioneering brand that encompasses full suite of products dedicated to advancing neuroscience research.
Aneuro’s products include target proteins for therapeutic research, biomarker proteins for diagnostic research, pre-formed fibrils (PFFs) for modeling neurodegeneration, neural factors for cell culture, antibodies for nerve cell identification and solutions for in vivo electrophysiology recordings. In addition, Aneuro also offers customized services tailored to the specific needs.
By providing these products and services, Aneuro aims to be a one-stop shop for neuroscience researchers, offering everything they need to advance their research from target discovery to therapeutic development. We are committed to continuous innovation and improvement, striving to bring the latest advances in neuroscience research to our customers.
Image credit: ACROBiosystems
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Their mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. They supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, ACROBiosystems delivers solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. ACROBiosystems empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine